|
| |
Contact details of Medimmune Pages on BioPortfolio:
BioPortfolio - MedImmune
Contact Details:. One MedImmune Way. Gaithersburg. MD. 20878. United States of America. Tel: (301) 398-0000. Fax: 301 527 4200. Email: infobusdev@medimmune.
...
http://www.bioportfolio.com/biocorporate/6860-MedImmune.html...
|
BioPortfolio - kemia inc.
5 Jul 2008 ... Contact Details:. 5871 Oberlin Drive, Suite 100. San Diego . ... MedImmune Ventures, Inc. is a wholly owned venture capital subsidiary of . ...
http://www.bioportfolio.com/search/kemia_inc..html...
|
Biotechnology, Pharmaceutical and Life Science Email addresses for ...
BioEmail has been expanded to include the contact details of budget holding ... MedImmune, 36. TenetHealth, 36. Advocatehealth, 34. LibertyMutual, 33 ...
http://www.bioportfolio.com/advertis/bioemail_company.htm...
|
BioPortfolio - Medimmune, Incorporated. - Profile
Page on BioPortfolio.com. (http://www.bioportfolio. com/biocorporate/32934-Medimmune%2C+Incorporated..html). Contact Details:.
One Medimmune Way ...
http://www.bioportfolio.com/biocorporate/32934-Medimmune,%2B...
|
BioPortfolio - Virosomes
Virosome studied by MedImmune, Biotechnology News: Jul 21 2008 3:02AM Matching: ... we have details of around 25 individuals working on Virosomes . ...
http://www.bioportfolio.com/indepth/Virosomes.html...
|
BioPortfolio - Medarex
Contact Details:. 707 State Road #206. Princeton. NJ. 08540. United States of America ... MedImmune initiates phase 2a trial of lupus drug MEDI-545 ...
http://www.bioportfolio.com/biocorporate/6759-Medarex.html...
|
BioPortfolio - Cambridge Antibody Technology - Profile
Contact Details:. Milstein BuildingGranta Park. Cambridge. Cambridgeshire .... Former MedImmune chief David Mott to leave AstraZeneca ...
http://www.bioportfolio.com/biocorporate/20327-Cambridge%2BA...
|
Drug Patent Expirations in May 2006
Medimmune Oncology :: NEUTREXIN :: trimetrexate glucuronate ... Complete details are provided for all FDA-approved small molecule drugs. ...
http://www.bioportfolio.com/biotech_news/thinkbiotech_3.htm...
|
BioPortfolio - Smallpox
MedImmune Inc, 297 N Bernardo Ave, Mountain View, CA 94043, USA. ... Smallpox scientists - we have details of around 767 individuals working on Smallpox . ...
http://www.bioportfolio.com/indepth/Smallpox.html...
|
BioPortfolio - Applied Genetic Technologies, Corporation,
Contact Details:. 11801 Research Drive, Suite D. Alachua. Florida. 32615. United States of America. Tel: 386.462.2204. Fax:. Email: Information@agtc.com ...
http://www.bioportfolio.com/biocorporate/18067-Applied_Genet...
|
Results from other life science and pharmaceutical sites:
BioPortfolio - MedImmune
Contact Details:. One MedImmune Way. Gaithersburg. MD. 20878. United States of America. Tel: (301) 398-0000. Fax: 301 527 4200. Email: infobusdev@medimmune.
...
http://www.bioportfolio.com/biocorporate/6860-MedImmune.html...
|
AstraZeneca International - pharmaceutical company, prescription ...
To allow you to view details relating to the Offer, you have to read the following then ... In addition, on May 3, 2007, MedImmune filed with the SEC a
...
http://www.astrazeneca.com/Article/511728.aspx...
|
MedImmune
MedImmune, Inc.: dedicated to advances in biotechnology and devoted to patient support. ... Press Releases · Product Information · Contact MedImmune ...
http://www.medimmune.com/...
|
MedImmune, Inc. is Awarded Contract by U.S. Department of Health ...
MedImmune, Inc. CONTACT: Media: Karen Lancaster, +1-301-398-5864, or Investors: PeterVozzo, +1-301-398-4358, both of MedImmune, Inc. ...
http://www.biospace.com/news_story.aspx?NewsEntityId=60211...
|
MedImmune Vaccines is grateful for the opportunity to review and ...
setting, MedImmune would favor retaining the current private distribution system until more. details are available concerning the infrastructure and ...
http://www.fda.gov/ohrms/DOCKETS/DOCKETS/04s0212/04S-0212-EC...
|
Offer to Purchase for Cash All Outstanding Shares of Common Stock ...
Tendering Shares” for further details. • if you hold your MedImmune shares through a broker or bank, you must contact your broker or bank and give ...
http://www.astrazeneca.com/sites/7/imagebank/typearticlepara...
|
MedImmune Response to NVPO Pandemic Plan
MedImmune Vaccines is grateful for the opportunity to review and provide ... private distribution system until more details are available concerning the ...
http://www.fda.gov/ohrms/DOCKETS/DOCKETS/04s0212/04S-0212-EC...
|
AstraZeneca Third Quarter 2007 Teleconference Script David Brennan
the inclusion of MedImmune—as a result of the expected seasonal trading ... I will leave the details of the year to date performance to the press release. ...
http://www.astrazeneca.com/sites/7/imagebank/typeArticlepara...
|
Nancy Kavanaugh, PhD
This letter constitutes Medimmune’s written response to the draft guidance ... The FDA should provide more details on the study population and isolation ...
http://www.fda.gov/OHRMS/DOCKETS/dockets/06d0088/06d-0088-EC...
|
AstraZeneca Press Release 23 April 2007
23 Apr 2007 ... AstraZeneca to acquire MedImmune for $58 per share in a fully recommended, .... Teleconference details. 11:30 BST, 12:30 CEST, 06:30 EDT ...
http://www.astrazeneca.com/sites/7/imagebank/typeArticlepara...
|
|
